niceritrol has been researched along with fibrinogen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, K; Handa, K; Hidaka, K; Matsunaga, A; Mori, T; Moriyama, K; Sasaki, J; Yuki, M | 1 |
Hamazaki, T; Hasunuma, K; Kobayashi, S; Shishido, H; Yano, S | 1 |
Fujino, A; Ogyu, A; Saito, T; Sano, R; Takenaka, K; Toyota, T; Yahata, Y | 1 |
1 trial(s) available for niceritrol and fibrinogen
Article | Year |
---|---|
Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia.
Topics: Adult; Aged; Apolipoproteins; Apolipoproteins E; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Glycoproteins; Humans; Hypercholesterolemia; Lipids; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Niceritrol; Phenotype; Triglycerides | 1992 |
2 other study(ies) available for niceritrol and fibrinogen
Article | Year |
---|---|
The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Viscosity; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Lipids; Male; Middle Aged; Niceritrol; Nicotinic Acids; Platelet Aggregation | 1985 |
Reduction by niceritrol treatment of serum lipoprotein(a) in normolipidemic patients with coronary artery disease.
Topics: Adult; Aged; Apolipoproteins; Apolipoproteins B; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Humans; Hypolipidemic Agents; Lipoprotein(a); Male; Middle Aged; Niceritrol; Regression Analysis | 1993 |